VideaHealth Artificial Intelligence Dental Assist Receives FDA Clearance

News
Article

VideaHealth's Dental Assist is now cleared by the United States Food and Drug Administration for the detection of dental diseases.

VideaHealth Artificial Intelligence Dental Assist Receives FDA Clearance. Image credit: © VideaHealth

VideaHealth Artificial Intelligence Dental Assist Receives FDA Clearance. Image credit: © VideaHealth

Dental artificial intelligence (AI) platform VideaHealth has achieved a groundbreaking milestone with the United States Food and Drug Administration (FDA) granting 510(k) clearance for their latest product, Videa Dental Assist. The clearance includes more than 30 AI algorithms, expanding AI detections to cover all of the most common dental diseases, according to a press release from VideaHealth.

Florian Hillen, CEO of VideaHealth, expressed the significance of this FDA clearance, stating in the press release, "This is one of the largest, most impactful FDA clearances in the history of health care and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients."

These new clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages 3 years and older, among many other AI models. These models are said to allow for detections across all ages, improving workflow and time-savings for dental professionals. Notably, some of these detections mark the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.

Dr Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental, expressed excitement about VideaHealth's expanding scope of AI capabilities, saying in the press release, "It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission, and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint."

Already embraced by thousands of clinicians, per VideaHealth, VideaAI has become the dental AI tool of choice for many, used daily to provide the best possible care for millions of patients. With this recent FDA clearance, VideaHealth aims to solidify its position as the first dental AI company to offer insights for virtually every disease state.

Recent Videos
GNYDM24 Product Focus: Josh Gosnell, Vice President, Business Development at Adit, explains how cloud-based analytics and patient communication software can enable practices to run more efficiently.
GNYDM24 Product Focus: Debra Engelhardt-Nash talks about how Weave's systems can help with increasing patient acceptance and with practices getting paid.
At DS World 24, Max Milz, Dentsply Sirona VP, Connected Technology Solutions, talks about the company's new Primescan 2 intraoral scanning solution and how it fits in with a variety of digital dentistry workflows.
At Dentsply Sirona World 2024, Henry Schein's Matt Kunzler talks about the brand new innovations from Dentsply Sirona, including Primescan 2, a first of its kind cloud native scanner, as well as Henry Schein's flex financing solutions.
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Related Content
© 2024 MJH Life Sciences

All rights reserved.